tiprankstipranks
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market
Holding TRDA?
Track your performance easily

Entrada Therapeutics Inc (TRDA) Financial Statements

85 Followers

Entrada Therapeutics Inc Financial Overview

Entrada Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $1.593; its P/E ratio is 12.48; Entrada Therapeutics Inc is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 19.57M$ 94.69M$ 59.12M$ 41.85M$ 43.73M
Gross Profit$ 19.57M$ 94.69M$ 59.12M$ 41.85M$ 43.73M
EBIT$ -15.93M$ 57.83M$ 21.11M$ 4.91M$ 18.06M
EBITDA$ -14.93M$ 60.77M$ 22.05M$ 5.64M$ 18.86M
Net Income Common Stockholders$ -14.03M$ 55.03M$ 23.50M$ -9.54M$ 35.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.05M$ 185.25M$ 68.44M$ 67.60M$ 51.88M
Total Assets$ 554.59M$ 581.96M$ 510.84M$ 469.19M$ 485.03M
Total Debt$ 61.31M$ 64.44M$ 66.43M$ 68.23M$ 69.07M
Net Debt$ -16.73M$ -120.81M$ -2.00M$ 628.00K$ 17.19M
Total Liabilities$ 132.14M$ 152.04M$ 241.48M$ 226.83M$ 238.37M
Stockholders Equity$ 422.45M$ 429.93M$ 269.37M$ 242.36M$ 246.66M
Cash Flow-
Free Cash Flow$ -24.91M$ 38.79M$ -26.36M$ -4.99M$ -25.94M
Operating Cash Flow$ -24.27M$ 39.83M$ -25.52M$ -4.01M$ -24.49M
Investing Cash Flow$ -82.93M$ -24.38M$ 26.15M$ 19.04M$ -3.74M
Financing Cash Flow$ -11.00K$ 101.37M$ 206.00K$ 690.00K$ 368.00K
Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History

Entrada Therapeutics Inc Debt to Assets

Entrada Therapeutics Inc Cash Flow

Entrada Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis